http://ir.ciphergen.com/preview/phoenix.zhtml?c=121814&p=irol-newsArticl...

OVA1 study: don't buy stock in Vermillion yet

A company called Vermillion is crowing about a poster released at the recent SGO meeting. They are developing an ovarian cancer screening test they call OvaCalc. We get very emotional here at InteractMD.com over ovarian cancer screening because of the disproportionately high burden this disease places on younger women. OvaSure seemed to self-destruct over consternation from the FDA...it'll come back from the dead if it really is a good test.

Syndicate content